ID: ALA2335474

Max Phase: Preclinical

Molecular Formula: C84H156N30O19

Molecular Weight: 1890.36

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O

Standard InChI:  InChI=1S/C84H156N30O19/c1-13-47(9)65(112-75(126)57(32-33-60(89)115)104-61(116)42-99-69(120)58(41-44(3)4)109-73(124)54(27-17-20-36-87)108-76(127)59-31-24-40-114(59)80(131)50(12)102-71(122)55(29-22-38-97-83(92)93)106-68(119)51(88)25-15-18-34-85)77(128)100-43-62(117)103-52(28-21-37-96-82(90)91)70(121)101-49(11)67(118)105-53(26-16-19-35-86)72(123)107-56(30-23-39-98-84(94)95)74(125)110-63(45(5)6)78(129)111-64(46(7)8)79(130)113-66(81(132)133)48(10)14-2/h44-59,63-66H,13-43,85-88H2,1-12H3,(H2,89,115)(H,99,120)(H,100,128)(H,101,121)(H,102,122)(H,103,117)(H,104,116)(H,105,118)(H,106,119)(H,107,123)(H,108,127)(H,109,124)(H,110,125)(H,111,129)(H,112,126)(H,113,130)(H,132,133)(H4,90,91,96)(H4,92,93,97)(H4,94,95,98)/t47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,63-,64-,65-,66-/m0/s1

Standard InChI Key:  FCDASIISGHHHHY-YHPXCVFHSA-N

Associated Targets(Human)

CaM kinase II alpha 1938 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1890.36Molecular Weight (Monoisotopic): 1889.2163AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Gomez-Monterrey I, Sala M, Rusciano MR, Monaco S, Maione AS, Iaccarino G, Tortorella P, D'Ursi AM, Scrima M, Carotenuto A, De Rosa G, Bertamino A, Vernieri E, Grieco P, Novellino E, Illario M, Campiglia P..  (2013)  Characterization of a selective CaMKII peptide inhibitor.,  62  [PMID:23395965] [10.1016/j.ejmech.2012.12.053]

Source